TREML2 (TREM-like transcript 2) is a member of the triggering receptor expressed on myeloid cells (TREM) family of proteins. It is a single-pass type I membrane protein with an Ig-like V-type domain that plays important roles in immune cell function, particularly in myeloid cells including [microglia](/cell-types/microglia), macrophages, and dendritic cells [1][2]. TREML2 has emerged as a significant protein in neurodegenerative disease research due to its genetic association with [Alzheimer's disease](/diseases/alzheimers-disease) risk and its role in microglial phagocytosis and neuroinflammation [3][4].
TREML2 (TREM-like transcript 2) is a member of the triggering receptor expressed on myeloid cells (TREM) family of proteins. It is a single-pass type I membrane protein with an Ig-like V-type domain that plays important roles in immune cell function, particularly in myeloid cells including [microglia](/cell-types/microglia), macrophages, and dendritic cells [1][2]. TREML2 has emerged as a significant protein in neurodegenerative disease research due to its genetic association with [Alzheimer's disease](/diseases/alzheimers-disease) risk and its role in microglial phagocytosis and neuroinflammation [3][4].
The TREM family includes several related proteins: TREM1, TREM2, TREML1, TREML2, TREML3, and TREML4. While TREM2 has received extensive attention in AD research following the discovery of disease-associated variants, TREML2 shares structural similarity and has complementary or distinct functions in immune regulation [5][6]. TREML2 is expressed primarily in myeloid cells and is particularly important in the central nervous system where it modulates microglial function.
Structure and Biochemistry
Protein Architecture
TREML2 is a type I transmembrane protein with the following structural features [7][8]:
Extracellular Ig-like domain: The N-terminal portion contains an immunoglobulin V-type (IgV) domain that mediates ligand binding. This domain shares approximately 40% sequence similarity with TREM2's IgV domain.
Transmembrane domain: A short hydrophobic transmembrane helix anchors the protein in the cell membrane
Cytoplasmic tail: Contains a short cytoplasmic domain with potential signaling motifs
Relationship to TREM2
TREML2 shares significant structural and functional homology with TREM2:
Both proteins have similar Ig-like extracellular domains
Both signal through the same adaptor protein DAP12 (TYROBP)
However, TREML2 has distinct ligand specificity and expression patterns
TREML2 may act as a functional paralog or decoy receptor for TREM2 ligands
Ligand Interactions
TREML2 binds to various ligands including [9][10]:
Lipids: Various lipid species including phosphatidylserine and oxidized lipids
Apolipoproteins: ApoE and other apolipoproteins
Bacterial products: Certain bacterial cell wall components
TREM2 ligands: May compete with or complement TREM2 ligand binding
Normal Physiological Function
Immune Cell Regulation
TREML2 plays multiple roles in immune cell function [11][12]:
Inflammatory Response Modulation
TREML2 regulates cytokine production by macrophages and dendritic cells
Can both enhance and suppress inflammatory responses depending on context
Modulates the balance between pro-inflammatory and anti-inflammatory states
Phagocytosis
TREML2 participates in cellular debris clearance
Involved in phagocytosis of apoptotic cells and pathogens
Complements TREM2-mediated phagocytosis in myeloid cells
Immune Cell Activation
Acts as a co-stimulatory molecule for T-cell activation
Modulates dendritic cell maturation and antigen presentation
Regulates platelet activation and function
Central Nervous System Function
In the brain, TREML2 is expressed by microglia and modulates [13][14]:
Microglial Phagocytosis
TREML2 contributes to amyloid-beta clearance
Regulates microglial uptake of cellular debris
Modifies the microglial inflammatory response to pathological stimuli
Neuroinflammation
TREML2 signaling influences cytokine production by microglia
Can modulate the neurotoxic vs. protective microglial phenotype
May be involved in the transition from acute to chronic neuroinflammation
Role in Neurodegenerative Diseases
Alzheimer's Disease
TREML2 is genetically and functionally associated with AD risk [15][16][17]:
Genetic Association
TREML2 variants influence AD risk, though with smaller effect size than TREM2
Certain TREML2 polymorphisms are associated with increased disease risk
The genetic effect may be independent of or interact with TREM2 variants
Microglial Function
TREML2 modulates microglial activation and phagocytosis
Influences amyloid clearance efficiency
Regulates neuroinflammation in the AD brain
Therapeutic Implications
TREML2 agonists may enhance beneficial microglial responses
Targeting TREML2 could complement TREM2-based therapies
May provide an alternative approach for AD immunotherapy
Parkinson's Disease
TREML2 may play a role in PD pathogenesis [18]:
Altered TREML2 expression in PD brain tissue
Potential involvement in alpha-synuclein clearance
May modulate microglial responses to dopaminergic neuron injury
Stroke and Ischemia
TREML2 has protective roles in ischemic injury [19]:
Modulates inflammatory responses following stroke
Promotes phagocytosis of necrotic debris
May influence recovery through immune modulation
Inflammatory and Autoimmune Diseases
TREML2 dysregulation contributes to various inflammatory conditions [20]:
Altered expression in autoimmune diseases
Modulates inflammatory responses in chronic inflammatory conditions
Potential therapeutic target for immune-mediated diseases
Therapeutic Targeting
TREM2/TREML2 Agonists
Several therapeutic approaches are being developed [21][22]:
Agonistic antibodies: Antibodies that activate TREM2/TREML2 signaling to enhance microglial function
Small molecule agonists: Compounds that stimulate TREM2/TREML2 signaling pathways
Protein replacement: Administration of soluble TREML2 or TREM2 ectodomains
Modulation Strategies
Therapeutic modulation approaches include:
Enhancing phagocytosis: Agonists to boost debris and amyloid clearance
Shifting microglial phenotype: Modulators to promote neuroprotective microglial states
Reducing neuroinflammation: Anti-inflammatory approaches via TREML2 modulation
Biomarker Potential
TREML2 may serve as a biomarker:
Soluble TREML2 (sTREML2) can be detected in cerebrospinal fluid
Levels may correlate with disease stage or progression
May help predict treatment response
Cross-Links
[TREM2](/proteins/trem2) — Related protein in TREM family, major AD risk factor
[TREML2 Gene](/genes/treml2) — Gene encoding TREML2 protein
[Alzheimer's Disease](/diseases/alzheimers-disease) — Primary disease association
[Parkinson's Disease](/diseases/parkinsons-disease) — Secondary disease association
[Microglia](/cell-types/microglia) — Primary cell type expressing TREML2
[Microglial phagocytosis](/mechanisms/microglial-phagocytosis) — Key function modulated by TREML2